Schroder Investment Management Group Has $36.22 Million Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Schroder Investment Management Group trimmed its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 5.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 405,847 shares of the company’s stock after selling 25,031 shares during the quarter. Schroder Investment Management Group owned approximately 2.69% of U.S. Physical Therapy worth $36,218,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bahl & Gaynor Inc. grew its holdings in shares of U.S. Physical Therapy by 135.4% during the fourth quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company’s stock valued at $23,076,000 after buying an additional 149,622 shares in the last quarter. State Street Corp boosted its position in U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after acquiring an additional 99,244 shares during the period. Copeland Capital Management LLC grew its stake in U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock valued at $74,459,000 after acquiring an additional 72,715 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of U.S. Physical Therapy in the 4th quarter valued at about $6,240,000. Finally, Southernsun Asset Management LLC lifted its position in shares of U.S. Physical Therapy by 10.5% in the third quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock worth $46,302,000 after purchasing an additional 52,062 shares in the last quarter.

U.S. Physical Therapy Trading Up 0.2 %

Shares of NYSE:USPH opened at $72.47 on Wednesday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $1.10 billion, a PE ratio of 77.10, a P/E/G ratio of 3.54 and a beta of 1.51. U.S. Physical Therapy, Inc. has a 1 year low of $69.99 and a 1 year high of $112.52. The firm has a fifty day moving average price of $82.57 and a 200 day moving average price of $86.44.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. Analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be given a $0.45 dividend. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.48%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 97.83%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on USPH. StockNews.com downgraded shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Friday, February 28th. Barrington Research lowered their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a report on Friday, February 28th. William Blair reiterated a “market perform” rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. JMP Securities initiated coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They issued an “outperform” rating and a $113.00 target price on the stock. Finally, JPMorgan Chase & Co. cut their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Wednesday, March 19th. One research analyst has rated the stock with a sell rating, one has given a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $109.00.

Insider Transactions at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.70% of the stock is owned by corporate insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.